MENU
PTH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PTH stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index")... Show more

Category: #Health
PTH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PTH with price predictions
Oct 01, 2026

PTH sees MACD Histogram just turned negative

PTH saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 31, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 43 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTH as a result. In 80 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

PTH moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for PTH entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTH advanced for three days, in 278 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

PTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Humana (NYSE:HUM), Illumina (NASDAQ:ILMN), Centene Corp (NYSE:CNC), Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.

Market Cap

The average market capitalization across the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF is 30.68B. The market cap for tickers in the group ranges from 671.04M to 78.76B. MRNA holds the highest valuation in this group at 78.76B. The lowest valued company is ZVRA at 671.04M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was 22%. For the same ETF, the average monthly price growth was 52%, and the average quarterly price growth was 685%. AGL experienced the highest price growth at 9%, while LQDA experienced the biggest fall at -61%.

Volume

The average weekly volume growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was 2%. For the same stocks of the ETF, the average monthly volume growth was 41% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 70
Price Growth Rating: 49
SMR Rating: 74
Profit Risk Rating: 69
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
PTH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com